Connect with us

IT Industry

SINTX TECHNOLOGIES ANNOUNCES ADJOURNMENT OF ANNUAL MEETING OF STOCKHOLDERS UNTIL JULY 12, 2019

GlobeNewswire

Published

on

Reading Time: 3 minutes

Annual Meeting adjourned solely with respect to Proposal 2 – Approval of Reverse Stock Split

SALT LAKE CITY, July 03, 2019 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) today announced that its 2019 Annual Meeting of Stockholders (“Annual Meeting”), was adjourned with respect to Proposal 2 – Approval of Reverse Stock Split. While Proposal 2 has exceeded 69% approval based on votes cast to date, approval of more than 50% of all outstanding shares of SINTX common stock as of March 6, 2019, is necessary for the proposal to be ratified and approved. At the meeting, it was deemed that the holders of a sufficient number of SINTX’s outstanding common stock have not yet submitted proxies to indicate how their shares should be voted and additional time was needed to collect the required votes. The adjournment will allow for the solicitation of additional votes on Proposal 2. The Annual Meeting will resume with respect to Proposal 2 at 10:00 a.m. MDT on July 12, 2019 at the company’s offices located at 1855 West 2100 South, Salt Lake City, UT 84119.

The company will continue to solicit proxies from stockholders with respect to Proposal 2 during the period of adjournment. Only stockholders of record on the record date of March 6, 2019 are entitled and are being requested to vote. No further action is required by any stockholder who has submitted his or her proxy card. The company’s Board of Directors and management respectfully request all such holders as of the record date who have not yet voted their shares to do so by 11:59 p.m. EDT on Thursday, July 11, 2019.

About SINTX Technologies

SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for biomedical applications, such as spine and dental implants. The core strength of SINTX Technologies is the research and development of medical-grade silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride spinal implants in its FDA registered and ISO 13485 certified manufacturing facility for CTL-Amedica, the exclusive retail channel for silicon nitride spinal implants.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”) that are subject to a number of risks and uncertainties. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. A discussion of those risks and uncertainties can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 11, 2019, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.

Important Information 

In connection with the solicitation of proxies, on March 25, 2019, SINTX Technologies, Inc. filed a definitive proxy statement with the Securities and Exchange Commission (the “SEC”) in connection with the Company’s 2019 Annual Meeting. SINTX’S STOCKHOLDERS ARE STRONGLY ADVISED TO READ THE DEFINITIVE PROXY MATERIALS AND ANY OTHER RELEVANT SOLICITATION MATERIALS FILED BY SINTX WITH THE SEC BEFORE MAKING ANY VOTING OR INVESTMENT DECISION BECAUSE THESE DOCUMENTS CONTAIN IMPORTANT INFORMATION. The Company’s proxy statement and any other materials filed by the Company with the SEC can be obtained free of charge at the SEC’s web site at www.sec.gov. The Company’s proxy statement, notice of annual meeting, and annual report to shareholders are available free of charge on our Investor Relations website at https://ir.sintx.com/annual-shareholder-materials. All stockholders may also write to us at the following address to request copies of these materials: SINTX Technologies, Inc. 1885 West 2100 South Salt Lake City, UT 84119 Attention: Corporate Secretary. The contents of the websites referenced above are not deemed to be incorporated by reference into the proxy statement.

For more information on SINTX Technologies or its silicon nitride material platform, please visit
www.sintx.com.

Contact:

SINTX Technologies 
801-839-3502
IR@sintx.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

IT Industry

Trakopolis Announces Results of Annual General and Special Meeting

GlobeNewswire

Published

on

Reading Time: 1 minute

CALGARY, Alberta, July 19, 2019 (GLOBE NEWSWIRE) — Trakopolis IoT Corp. (TSXV: TRAK) today reported the results of its Annual General and Special Meeting of Shareholders held on Friday, July 19, 2019 (the “Meeting“).

At the Meeting, shareholders approved the appointment of Tracy Graf, Brent Moore, Chris Burchell, Anthony Dutton, Cameron Olson, Gil Sonnenberg and Frank Turner as directors of the company. Shareholders also approved the reappointment of KPMG LLP as the Company’s auditors as well as the Company’s Stock Option Plan.

About Trakopolis

Trakopolis is a Software as a Service (SaaS) company with proprietary, cloud-based solutions for real-time tracking, data analysis and management of corporate assets such as equipment, devices, vehicles and workers. The Company’s asset management platform works across a variety of networks and devices. Trakopolis has a diversified revenue stream from many verticals including oil and gas, forestry, transportation, construction, rentals, urban services, mining, government and others.

FOR FURTHER INFORMATION, PLEASE CONTACT

Brent Moore, President and Chief Executive Officer
Trakopolis IoT Corp.
Telephone: (403) 450-7854
Email: bmoore@trakopolis.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Continue Reading

IT Industry

West High Yield Completes Second Tranche of Private Placement and Terminates Market Making Services Agreement

GlobeNewswire

Published

on

Reading Time: 4 minutes

CALGARY, Alberta, July 19, 2019 (GLOBE NEWSWIRE) — West High Yield (W.H.Y.) Resources Ltd. (“West High Yield” or the “Company“) (TSXV: WHY) announces that it has completed the second and final tranche of its previously announced non-brokered private placement of units (“Units“). The Company issued 258,000 Units at a price of $0.25 per Unit for gross proceeds of $64,500 under the second tranche. The Company wishes to correct its statement in the press release issued June 7 regarding the number of units issued pursuant to the first tranche closing. In total, 609,000 units were issued as part of the first tranche for gross proceeds of $152,250.

In aggregate, the Company issued 867,000 Units at a price of $0.25 per Unit for gross proceeds of $216,750 under the private placement. Each Unit consists of one common share in the capital of the Company (a “Common Share“) and one-third of one common share purchase warrant (a “Warrant“). Each whole Warrant entitles the holder to purchase one additional Common Share at an exercise price of $0.45 for a period of one year from the date of issuance of the Warrant. 

All of the securities issued under the private placement are subject to a four month resale restriction. The private placement is subject to receipt of all necessary regulatory approvals including final approval of the TSX Venture Exchange. 

Net proceeds are expected to be used for the environmental base line study, environmental assessment study and mine plan and permit application and Industrial Mineral Mine Permit application for the Company’s Record Ridge deposit near Rossland, British Columbia and general corporate purposes. Although the Company intends to use the proceeds of the offering as described above, the actual allocation of proceeds may vary from the uses set out above, depending upon future operations, events or opportunities. 

An insider of the Company subscribed for 133,000 Units, for a total of approximately 15% of the private placement. The private placement is therefore deemed to be a “related party transaction” as defined under Multilateral Instrument 6-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“). Neither the Company, nor to the knowledge of the Company after reasonable inquiry, the insider participant in the private placement, has knowledge of any material information concerning the Company or its securities that has not been generally disclosed.

The private placement is exempt from the formal valuation and minority shareholder approval requirements of MI 61-101 (pursuant to subsections 5.5(c) and 5.7(1)(b)) as it was a distribution of securities for cash and neither the fair market value of the Units distributed to, nor the consideration received from, the insider participant exceeded $2,500,000.

The Company also announces termination of the agreement with Questrade, Inc. to provide market making services to the Company previously announced May 10, 2019.

About West High Yield

West High Yield is a publicly traded junior mining exploration company focused on the acquisition, exploration and development of mineral resource properties in Canada with a primary objective to locate and develop economic gold, nickel and magnesium properties.

For further information please contact:
 
 
Frank Marasco
President and Chief Executive Officer
West High Yield (W.H.Y.) Resources Ltd.
Telephone: (403) 660-3488
Facsimile: (403) 206-7159
Email: frank@whyresources.com 
Dwayne Vinck
Chief Financial Officer
West High Yield (W.H.Y.) Resources Ltd.
Telephone: (403) 257-2637
Facsimile: (403) 206-7159
Email: vinck@shaw.ca 

Reader Advisory

This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. The use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “objective”, “ongoing”, “may”, “will”, “project”, “should”, “believe”, “plans”, “intends” and similar expressions are intended to identify forward-looking information or statements. More particularly and without limitation, this press release contains forward looking statements and information concerning the terms of the proposed non-brokered private placement of Units, the proposed use of proceeds and the Company’s business plans. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information because the Company can give no assurance that they will prove to be correct. 

Forward-looking information is based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those anticipated in the forward-looking information. Some of the risks and other factors that could cause the results to differ materially from those expressed in the forward-looking information include, but are not limited to: general economic conditions in Canada and globally; industry conditions, including governmental regulation; failure to obtain industry partner and other third party consents and approvals, if and when required; the availability of capital on acceptable terms; the need to obtain required approvals from regulatory authorities; stock market volatility; competition for, among other things, skilled personnel and supplies; changes in tax laws; and the other factors. Readers are cautioned that this list of risk factors should not be construed as exhaustive. 

Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date hereof, and to not use such forward-looking information for anything other than its intended purpose. The Company undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

Not for distribution in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any securities in the United States. The securities of the Company will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) and may not be offered or sold within the United States or to, or for the account or benefit of U.S. persons except in certain transactions exempt from the registration requirements of the U.S. Securities Act.

Continue Reading

IT Industry

Breast Reconstruction Market Size to Hit USD 3.6 Bn by 2026

GlobeNewswire

Published

on

Reading Time: 3 minutes

Acumen Research and Consulting, recently published report on “Breast reconstruction Market Size, Share, Trends, Scope, Growth and Forecast 2019-2026”.

LOS ANGELES, July 19, 2019 (GLOBE NEWSWIRE) — The global breast reconstruction market is estimated to grow at a significant rate of 6.5% during the forecasted period 2019 to 2026 and is expected to reach over 3.6 billion by 2026.

Free Download Sample Report Pages for Better understanding@ https://www.acumenresearchandconsulting.com/request-sample/1535

The global breast reconstruction market is driven by rising number of breast implantation across the globe, increasing prevalence of breast cancer, and increasing healthcare expenditure by major economies across the world. Investments in R&D and increasing government support the breast reconstruction market growth. Moreover, surge in the per capita healthcare expenditure, are some of the vital factors driving the global breast reconstruction market growth during the forecast period 2019-2026. Other factors such as increasing awareness among people regarding breast reconstruction and changing lifestyle are likely to boost the market growth in the near future. However, lack of skilled professionals in the under developed region including Latin America and developing region including the Middle East & Africa is the major factor which is likely to slow the market growth during the forecast period 2019–2026.

The global breast reconstruction market is segmented by product, shape, and end user.

On the basis of product, the breast reconstruction market is segmented into tissue expander, implants, silicone breast implants, and others. Silicone breast implants holds the major share in the global market owing to the various advantages over old and other available options.

Based on shape, the global breast reconstruction market is segmented into round, and anatomical.

Based on end user, the breast reconstruction market is segregated into hospitals, cosmetology clinics, and ambulatory surgical centers, and others.

The global breast reconstruction market is segmented on the basis of the region covering North America, Asia Pacific, Europe, Latin America, and the Middle East & Africa.

View Detailed Information with Complete TOC@ https://www.acumenresearchandconsulting.com/breast-reconstruction-market

North America Breast reconstruction market is expected to be the biggest market across the globe. Growth of the North America breast reconstruction market is attributed to the advancements in the medical technology as well as the extensive use of new implants. The U.S. Breast reconstruction market is expected to account for largest in the North America market owing to the technological advancements in the region and high awareness regarding breast reconstruction and presence of huge patient population. Increasing investment in research and development by major players has supported the growth of the breast reconstruction market. Moreover, high spending power of the people will support the breast reconstruction market in North America. Growth of the Europe breast reconstruction market is attributed to the increasing government support and presence of major players in the region. Ongoing research & development in the region over breast reconstruction is the other factor which is expected to propel the market growth further. Asia Pacific is the fastest growing market for breast reconstruction and is expected to grow at high pace owing to the entry of major players in the region due to presence of huge population base suffering from breast cancer. Countries such as Japan, China, and India are considered as the major countries contributing to the market growth, owing to the availability of research facilities. Additionally, the growth is attributed to the presence of skilled workforce such as several research scientists and others. The market in the Middle East and Africa holds the least but growing market share owing to the rising demand for the poor economic condition, research activities and healthcare services, and less development in medical facilities especially in African region.

Some of the key players in the global breast reconstruction market include Mentor Worldwide LLC; POLYTECH Health & Aesthetics GmbH; Sientra, Inc.; Deal Implant Incorporated; Allergan Inc.; Establishment Labs S.A; GROUPE SEBBIN SAS; Integra LifeSciences Corporation; RTI Surgical Holdings, Inc.; and GC Aesthetics.

Acumen Research and Consulting Enters Partnership with MARKETWATCH, Click Here

Request for Customization@ https://www.acumenresearchandconsulting.com/request-customization/1535

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1535

If you would like to place an order or have any questions, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

For Latest Update Follow Us:

https://twitter.com/AcumenRC

https://www.facebook.com/acumenresearchandconsulting

https://www.linkedin.com/company/acumen-research-and-consulting/

Continue Reading

Font Resizer

Subscribe to PICANTE via Email

Enter your email address to subscribe to PICANTE and receive notifications of new posts by email.

Follow us on Facebook

Read more from our authors

Follow our Tweets

Trending

Please turn AdBlock off